Please login to the form below

Cipralex

This page shows the latest Cipralex news and features for those working in and with pharma, biotech and healthcare.

mature products like epilepsy therapies Onfi (clobazam) and Sabril (vigabatrin) and antidepressant Cipralex (escitalopram).

Lundbeck’s key products shine in Q2 but problems remain

Sales of antidepressant Cipralex (escitalopram) and anti-epileptic Sabril (vigabatrin) also suffered double-digit declines, more than offsetting growth of Lundbeck’s four strategic brands.
Surging sales of Lundbeck's CNS drugs assist recovery

Two newer antidepressants help boost sales after Cipralex patent ends. . Surging sales of four new central nervous system drugs helped Denmark's Lundbeck post a 5% sales increase in the second ... Those gains were encouraging and helped offset the
Lundbeck to cut 1,000 jobs in major restructure

sales from drugs such as depression treatment Cipralex (escitalopram).
US filing aims to elevate Brintellix above its competition

Brintellix has been on the market in the US since 2013 and has been positioned as a successor to its older antidepressant Cipralex (escitalopram), which was selling around $2bn a year
Schultz takes Lundbeck helm after leaving Novo Nordisk

to continued generic competition to Alzheimer's therapy Ebixa (memantine) and antidepressant Cipralex (escitalopram). ... The company's newer drugs will need to pick up the pace to offset the impact of genericisation however, given that Cipralex sales

More from news
Approximately 3 fully matching, plus 35 partially matching documents found.

Case study: multi channel depression awareness campaign

Fredrik Jerre,. Head of Global Marketing,. Cipralex, Lundbeck.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Medical Writers (All levels) Editorial / Scientific Leads & ...: Highly Competitive Remuneration packages

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Account Manager - Creative Healthcare Communications - South Wes...: Excellent Remuneration

Group Account Director, Healthcare Advertising/ Brand comms, Lon...: 8 month contract up to £90K

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Editorial Traffic Manager, Medical Communications Agency, London...: up to £45K

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Head of Strategic Planning, Healthcare Advertising/ Brand comms,...: Six figure salary

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Add my company

Valid Insight is an award-winning pharmaceutical global market access consultancy....

How innovating study sites can improve patient recruitment efficiency: There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
Avoiding A Series of Unfortunate Events: launch lessons from lockdown: Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it: If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....

Email:
Password: